A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids

Inclusion Criteria: \- Pre-menopausal adult women with a diagnosis of moderate or severe symptoms of uterine fibroids who are initiating treatment with ESMYA. Exclusion Criteria: * Patient is pregnant or plans to become pregnant in the next 3 months, * Patient is breastfeeding, * Patient has genital bleeding of unknown etiology or not due to uterine fibroids, * Patient has been diagnosed with uterine, cervical, ovarian or breast cancer, * Patient is using an investigational drug/therapy or has discontinued the use of an investigational drug/therapy within 30 days prior to study enrollment, * Patient has hypersensitivity to the active substance of ESMYA or to one of its excipients